ATCC 100 Years Logo Anniversary ATCC 100 Years Logo Anniversary Cart 0
  • Quick Order
  • Careers
  • Support

Quantitative Genomic DNA from Vibrio cholerae strain N16961

BAA-3362DQ

This product is quantitative genomic DNA derived from ATCC BAA-3362, which is an ATCC manufactured and accessioned progeny of 39315 cited in US Patent Number 4,935,364.
Product category
Bacteria
Product type
Nucleic acid
Molecular standard
Organism
Vibrio cholerae Pacini
Type strain
No
Genome sequenced strain
Yes
Applications
Assay development
Infectious disease research
Respiratory disease research
Specification range
≥1 x 105 copies/μL
Volume
100 μL
Product format
Frozen
Storage conditions
-20°C or colder
Buy Now
Price: $631.00 ea
Discounts may be available for our fellow nonprofit organizations. Login to see your price.

Generally ships within 1-3 business days

Documentation

ATCC determines the biosafety level of a material based on our risk assessment as guided by the current edition of Biosafety in Microbiological and Biomedical Laboratories (BMBL), U.S. Department of Health and Human Services. It is your responsibility to understand the hazards associated with the material per your organization’s policies and procedures as well as any other applicable regulations as enforced by your local or national agencies.

Required Products

These products are vital for the proper use of this item and have been confirmed as effective in supporting functionality. If you use alternative products, the quality and effectiveness of the item may be affected.

Detailed product information

General

Specific applications
ATCC® Genuine Nucleics can be used for assay development, verification, validation, monitoring of day-to-day test variation, and lot-to-lot performance of molecular-based assays. The quantitative format allows for the generation of a standard curve for quantitative PCR (qPCR) to determine bacterial load.

Characteristics

Antigenic properties
Biovar eltor
Serotype
O:1, Inaba biovar eltor
Comments
Genomic DNA isolated from a preparation of Vibrio cholerae strain N16961 (ATCC BAA-3362). The source organism is also available through the ATCC catalog.

Handling information

Handling procedure
  1. Thaw the vial at room temperature and immediately place on ice. Avoid exposing the DNA to repeated freeze-thaw cycles as it may result in degradation.
  2. Gently mix the sample to ensure an even distribution of material.
  3. Briefly centrifuge the tube before opening to ensure all liquid is at the bottom.
Handling notes
Aliquoting is highly recommended to avoid multiple freeze-thaws.

History

Deposited as
Quantitative genomic DNA from an ATCC accessioned progeny of Vibrio cholerae strain N16961 (ATCC BAA-3362) cited in US Patent Number 4,935,364 as 39315.
Cross references
GenBank AE003852 Vibrio cholerae O1 biovar eltor str. N16961 chromosome I, complete sequence.

Legal disclaimers

Intended use
This product is intended for laboratory research use only. It is not intended for any animal or human therapeutic use, any human or animal consumption, or any diagnostic use.
Warranty

The product is provided 'AS IS' and the viability of ATCC® products is warranted for 30 days from the date of shipment, provided that the customer has stored and handled the product according to the information included on the product information sheet, website, and Certificate of Analysis. For living cultures, ATCC lists the media formulation and reagents that have been found to be effective for the product. While other unspecified media and reagents may also produce satisfactory results, a change in the ATCC and/or depositor-recommended protocols may affect the recovery, growth, and/or function of the product. If an alternative medium formulation or reagent is used, the ATCC warranty for viability is no longer valid.  Except as expressly set forth herein, no other warranties of any kind are provided, express or implied, including, but not limited to, any implied warranties of merchantability, fitness for a particular purpose, manufacture according to cGMP standards, typicality, safety, accuracy, and/or noninfringement.

Disclaimers

This product is intended for laboratory research use only. It is not intended for any animal or human therapeutic use, any human or animal consumption, or any diagnostic use. Any proposed commercial use is prohibited without a license from ATCC.

While ATCC uses reasonable efforts to include accurate and up-to-date information on this product sheet, ATCC makes no warranties or representations as to its accuracy. Citations from scientific literature and patents are provided for informational purposes only. ATCC does not warrant that such information has been confirmed to be accurate or complete and the customer bears the sole responsibility of confirming the accuracy and completeness of any such information.

This product is sent on the condition that the customer is responsible for and assumes all risk and responsibility in connection with the receipt, handling, storage, disposal, and use of the ATCC product including without limitation taking all appropriate safety and handling precautions to minimize health or environmental risk. As a condition of receiving the material, the customer agrees that any activity undertaken with the ATCC product and any progeny or modifications will be conducted in compliance with all applicable laws, regulations, and guidelines. This product is provided 'AS IS' with no representations or warranties whatsoever except as expressly set forth herein and in no event shall ATCC, its parents, subsidiaries, directors, officers, agents, employees, assigns, successors, and affiliates be liable for indirect, special, incidental, or consequential damages of any kind in connection with or arising out of the customer's use of the product. While reasonable effort is made to ensure authenticity and reliability of materials on deposit, ATCC is not liable for damages arising from the misidentification or misrepresentation of such materials.

Please see the material transfer agreement (MTA) for further details regarding the use of this product. The MTA is available at www.atcc.org.

Frequently Asked Questions

References

Curated Citations

Levine MMImmunity to cholera as evaluated in volunteersIn: Levine MMCholera and related diarrheasBaselS. Kargerpp. 195-203, 1980

Black RE, et alVolunteer studies in development of vaccines against cholera and enterotoxigenic Escherichia coli: a reviewIn: Black RE, et alAcute enteric infections in children: new prospects for treatment and preventionAmsterdamElsevierpp. 443-459, 1981

Kaper JB, Levine MM. Method of isolating restriction fragment deletions in Vibrio cholerae, products thereof. US Patent 5,135,862 dated Aug 4 1992

Fasano A, et al. Method of isolating restriction fragment deletions in Vibrio cholerae, and products thereof. US Patent 5,470,729 dated Nov 28 1995

Kaper JB, Levine MM. Method of isolating restriction fragment deletions in Vibrio cholerae and products thereof. US Patent 4,935,364 dated Jun 19 1990

For product-related inquiries and issues, contact Product Experience:

Message Us

Hours of Operation

Monday - Friday
9:00am - 5:00pm
US Eastern Time